News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
679,174 Results
Type
Article (38786)
Company Profile (249)
Press Release (640139)
Section
Business (203541)
Career Advice (1977)
Deals (35344)
Drug Delivery (78)
Drug Development (80622)
Employer Resources (167)
FDA (16022)
Job Trends (14778)
News (343745)
Policy (32407)
Tag
Academia (2528)
Africa (711)
Alliances (48976)
Alzheimer's disease (1147)
Approvals (15941)
Arizona (174)
Artificial intelligence (69)
Asia (36808)
Australia (5984)
Bankruptcy (350)
Best Places to Work (11287)
Biosimilars (63)
Biotechnology (176)
C2C Services and Suppliers (78790)
California (1899)
Canada (940)
Cancer (496)
Career advice (1647)
Cell therapy (121)
China (150)
Clinical research (63231)
Collaboration (142)
Colorado (79)
Compensation (83)
Connecticut (75)
COVID-19 (2488)
Cystic fibrosis (73)
Data (318)
Diabetes (81)
Diagnostics (5974)
Drug pricing (64)
Earnings (83654)
Employer resources (142)
Europe (78641)
Events (107828)
Executive appointments (156)
FDA (16252)
Florida (268)
Funding (149)
Gene therapy (93)
GLP-1 (511)
Government (4291)
Healthcare (18613)
Hotbed/Location (480947)
Illinois (256)
Indiana (148)
Infectious disease (2517)
Inflammatory bowel disease (91)
Interviews (305)
IPO (16204)
Job creations (3618)
Job search strategy (1412)
Kansas (94)
Layoffs (393)
Legal (7830)
Lung cancer (111)
Manufacturing (88)
Maryland (400)
Massachusetts (1535)
Medical device (13046)
Medtech (13051)
Mergers & acquisitions (19018)
Metabolic disorders (249)
Michigan (124)
Minnesota (214)
Neuroscience (1295)
New Jersey (583)
New York (599)
NextGen Class of 2024 (6479)
Non-profit (4457)
North Carolina (589)
Northern California (831)
Obesity (148)
Ohio (106)
Opinion (171)
Patents (75)
Pennsylvania (585)
People (55853)
Phase I (19588)
Phase II (27846)
Phase III (20811)
Pipeline (113)
Postmarket research (2546)
Preclinical (8317)
Press Release (64)
Radiopharmaceuticals (230)
Rare diseases (130)
Real estate (5882)
Recruiting (63)
Regulatory (21202)
Research institute (2304)
Resumes & cover letters (346)
South America (1085)
Southern California (773)
Startups (3559)
Texas (242)
United States (8620)
Vaccines (477)
Washington State (253)
Weight loss (128)
Date
Last 7 days (608)
Last 30 days (2305)
Last 365 days (36957)
2024 (26274)
2023 (40075)
2022 (51173)
2021 (55713)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32112)
2016 (31480)
2015 (37553)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
679,174 Results for "endologix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Endologix Appoints Graham Phillips as Chief Operating Officer
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce the appointment of Graham Phillips as its new Chief Operating Officer, effective immediately.
June 18, 2024
·
3 min read
Business
Endologix Appoints Mike Mathias as Chief Commercial Officer
Endologix LLC announced the appointment of Mike Mathias as the company’s Chief Commercial Officer, effective immediately.
March 5, 2024
·
3 min read
Business
Endologix Announces that Art Taylor Joins Board of Directors
Endologix LLC is pleased to announce that Art Taylor has been appointed to the Endologix Board of Directors.
January 25, 2024
·
2 min read
Business
Endologix Announces that Scott Ward Joins Board of Directors
Endologix LLC is pleased to announce that Scott Ward has been appointed to the Endologix Board of Directors.
January 9, 2024
·
3 min read
Biotech Beach
Endologix to Present at Upcoming LSI US ’24 Emerging Medtech Summit
Endologix LLC today announced that Matt Thompson, President and CEO, will present at the Life Science Intelligence (LSI) USA ’24 Emerging Medtech Summit. Scheduled for March 20, 2024, at 10:55 am PT.
March 14, 2024
·
1 min read
Biotech Beach
Endologix Initiates Percutaneous Transmural Arterial Bypass (PTAB)1 Post-Market Study
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced the initiation of the PTAB1 Post-Market Study.
February 29, 2024
·
3 min read
Biotech Beach
Endologix to Present in Two Upcoming Healthcare Conferences
Endologix LLC announced today that the company will be presenting in two upcoming healthcare conferences.
November 9, 2023
·
1 min read
Business
Endologix Announces that Lucas Buchanan Joins Board of Directors
Endologix LLC is pleased to announce that Lucas Buchanan has been appointed to the Endologix Board of Directors.
August 24, 2023
·
3 min read
Policy
Endologix announces the U. S. Centers for Medicare & Medicaid Services granted a Transitional Pass-Through (TPT) Payment for the DETOUR™ System
Endologix LLC announces that the U. S. Centers for Medicare & Medicaid Services granted a Transitional Pass-Through Payment for the DETOUR System, effective January 1, 2024.
December 27, 2023
·
4 min read
Biotech Beach
Endologix Announces Results of Pooled Analysis of DETOUR1 and DETOUR2 Studies at 2023 VIVA Late-Breaking Clinical Trial Session
Endologix LLC announced results from a pooled analysis of DETOUR1 and DETOUR2 Studies evaluating Percutaneous Transmural Arterial Bypass with the DETOUR System.
November 2, 2023
·
5 min read
1 of 67,918
Next
